ArticleHead & neck oncology2012

The use of specific anti-growth factor antibodies to abrogate the oncological consequences of transfusion in head & neck squamous cell carcinoma: an in vitro study.

Tahwinder Upile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.